Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SL-28

Snippet

Sponsor: Second Life Therapeutics | Conditions: Head & Neck Cancer, Pancreas Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING